Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Yeungnam University Journal of Medicine ; : 133-144, 2011.
Article in Korean | WPRIM | ID: wpr-29013

ABSTRACT

BACKGROUND: Tigecycline (TIG), a new broad-spectrum glycylcycline with anti-multidrug-resistant-(MDR)-pathogen activity, was launched in March 2009 in South Korea, but there are insufficient clinical studies on its use in the country. As such, this study was performed to analyze cases of severe MDR-pathogen-caused infections treated with TIG. METHODS: Patients treated with TIG within the period from May 2009 to June 2010 were enrolled in this study. Their clinical and microbiologic data were reviewed retrospectively. RESULTS: Twenty-one patients were treated with TIG for complicated skin and soft-tissue infections (cSSTIs) (42.9%), complicated intra-abdominal infections (cIAIs) (38.1%), or pneumonia (19.1%) caused by MDR pathogens like carbapenem-resistant Acinetobacter baumannii (76.2%), methicillin-resistant Staphylococcus aureus (61.9%), extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae (38.1%), and penicillin-resistant Enterococcus species (33.3%). Thirteen patients (61.9%) had successful clinical outcomes while five (23.8%) died within 30 days. The rate of clinical success was highest in cSSTI (77.8%), followed by cIAI (50%) and pneumonia (50%), and the mortality rate was highest in pneumonia (50%), followed by cIAI (25%) and cSSTI (11.1%). CONCLUSION: Tigecycline therapy can be an option for the treatment of severe MDR-pathogen-caused infections in South Korea. Due to its high risk of failure and mortality, however, prudence is required in its clinical use for the treatment of severe infections like nosocomial pneumonia.


Subject(s)
Humans , Acinetobacter baumannii , Drug Resistance , Enterococcus , Escherichia coli , Intraabdominal Infections , Klebsiella pneumoniae , Methicillin-Resistant Staphylococcus aureus , Minocycline , Pneumonia , Republic of Korea , Skin , Tetracyclines
2.
Korean Journal of Gastrointestinal Endoscopy ; : 428-432, 2011.
Article in Korean | WPRIM | ID: wpr-150380

ABSTRACT

Hemobilia is a rare upper gastrointestinal (GI) bleeding phenomenon usually caused by trauma but may occur due to various liver and pancreatobiliary diseases. Causes related to gallbladder disease include vascular disorders, malignancy, polyps, heterotopic GI mucosa, acalculous inflammation, and most commonly gallstones. Most cases are treated with a cholecystectomy. If hemobilia is detected, efforts must be made to exclude malignancy because hemobilia develops from both benign and malignant disease. Particularly in gallbladder disease with hemobilia, the possibility of gallbladder carcinoma should be considered. We report two cases of hemoblia by endoscopic retrograde cholangiopancreatography and duodenoscopy, with a review of the literature. The first case was xanthoglanulomatous cholesystitis and the second case was gallbladder cancer disclosed by cholecystectomy.


Subject(s)
Cholangiopancreatography, Endoscopic Retrograde , Cholecystectomy , Cholecystitis , Duodenoscopy , Gallbladder , Gallbladder Diseases , Gallbladder Neoplasms , Gallstones , Granuloma , Hemobilia , Hemorrhage , Inflammation , Liver , Mucous Membrane , Polyps , Xanthomatosis
3.
Korean Journal of Gastrointestinal Endoscopy ; : 323-326, 2011.
Article in Korean | WPRIM | ID: wpr-175658

ABSTRACT

Pancreatic cancer is usually unresectable upon diagnosis, and treatment aims to optimize the quality of the patient's life by managing symptoms, and, particularly, by providing adequate pain control. When the pain is refractory to opioids, interventions such as celiac plexus neurolysis (CPN) can be considered. Endoscopic ultrasound (EUS)-guided CPN has been introduced for pancreatic cancer. Reported herein is a case of a 75 year-old man with pancreatic cancer who was treated with opioids due to severe abdominal pain. EUS-guided CPN was performed for pain control, and the opioid administration was discontinued as the pain improved dramatically. However, the patient experienced opioid withdrawal symptoms, including anxiety, insomnia, nausea, and vomiting. Thus, although EUS-guided CPN successfully reduced pain in a patient undergoing such treatment and to whom opioid was administered, opioid administration should not be abruptly discontinued. Rather, the opioid dose should be reduced gradually to avoid drug withdrawal.


Subject(s)
Humans , Abdominal Pain , Analgesics, Opioid , Anxiety , Celiac Plexus , Nausea , Pancreatic Neoplasms , Sleep Initiation and Maintenance Disorders , Substance Withdrawal Syndrome , Vomiting
4.
The Korean Journal of Gastroenterology ; : 377-381, 2010.
Article in Korean | WPRIM | ID: wpr-51784

ABSTRACT

Mesothelioma is a rare aggressive tumor arising from the mesothelial cell and regarded as universally fatal disease with average survival around 1 year. The incidence rate is varied from one to forty per million in different countries and increasing by the year. The most common site of tumor origin is the pleura and only 20% to 33% of mesothelioma arise from the peritoneum. There are increasing reports of malignant mesothelioma with forty to fifty fatal cases per year in Korea. Histological studies with immunohistochemical stain is helpful for the diagnosis of peritoneal mesothelioma and imaging modality alone is not sufficient for diagnosis, so it is difficult to confirm diagnosis. A 64-year-old male patient was admitted to the hospital with a palpable mass on abdomen. The 6x6 cm sized huge mass was seen on the body of stomach adjacent to the peritoneum. We report a case of malignant peritoneal mesothelioma without evident exposure to asbestos, of which direct invasion to the gastric mucosa was confirmed by endoscopic biopsy and immunohistochemical stain.


Subject(s)
Humans , Male , Middle Aged , Gastric Mucosa/pathology , Mesothelioma/diagnosis , Neoplasm Invasiveness , Peritoneal Neoplasms/diagnosis , Stomach Neoplasms/pathology , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL